Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,427.60
(
-2.28%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
6.18%
)
Bitcoin
65,970.99
(
-4.09%
)
News Focus
News Focus
Post# of 257298
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122816
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: JohnWayne post# 151655

Friday, 11/02/2012 4:42:13 PM

Friday, November 02, 2012 4:42:13 PM

Post# of 257298
FDA approves Xarelto for treatment of PE and secondary prevention of VTE (today was the PDUFA date):

#msg-81102867

This is the same indication where the Europe’s CHMP approved Xarelto two weeks ago (#msg-80711606). JNJ is Bayer's partner on Xarelto in the US market.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now